Cargando…

Osteoglycin: An ECM Factor Regulating Fibrosis and Tumorigenesis

The extracellular matrix (ECM) is made up of noncellular components that have special properties for influencing cell behavior and tissue structure. Small leucine-rich proteoglycans (SLRPs) are nonfibrillar ECM components that serve as structural scaffolds and signaling molecules. osteoglycin (OGN),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nulali, Jiayida, Zhan, Ming, Zhang, Kaiwen, Tu, Pinghui, Liu, Yu, Song, Huaidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687868/ https://www.ncbi.nlm.nih.gov/pubmed/36421687 http://dx.doi.org/10.3390/biom12111674

Ejemplares similares

Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs
por: Chen, Xia, et al.
Publicado: (2017)

The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis
por: Kampmann, Andreas, et al.
Publicado: (2008)

Osteoglycin, a novel coordinator of bone and glucose homeostasis
por: Lee, N.J., et al.
Publicado: (2018)

Osteoglycin – A switch from angiogenesis to T-cell recruitment?
por: Dimberg, Anna
Publicado: (2018)

New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction
por: Zhao, Xiangyu, et al.
Publicado: (2022)

Low Levels of Plasma Osteoglycin in Patients with Complex Coronary Lesions
por: Seki, Toshiki, et al.
Publicado: (2018)

Osteoglycin-induced VEGF Inhibition Enhances T Lymphocytes Infiltrating in Colorectal Cancer
por: Hu, Xiang, et al.
Publicado: (2018)

C/EBPβ LIP augments cell death by inducing osteoglycin
por: Wassermann-Dozorets, Rina, et al.
Publicado: (2017)

Osteoglycin inhibition by microRNA miR-155 impairs myogenesis
por: Freire, Paula Paccielli, et al.
Publicado: (2017)

Associations of Circulating Osteoglycin With Bone Parameters and Metabolic Markers in Patients With Diabetes
por: Starup-Linde, Jakob Kau, et al.
Publicado: (2021)

Vertebrate SLRP family evolution and the subfunctionalization of osteoglycin gene duplicates in teleost fish
por: Costa, R. A., et al.
Publicado: (2018)

Serum levels of iCAF‐derived osteoglycin predict favorable outcome in pancreatic cancer
por: Dings, Mark P. G., et al.
Publicado: (2022)

Peri-adipocyte ECM remodeling in obesity and adipose tissue fibrosis
por: Chun, Tae-Hwa
Publicado: (2012)

Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling
por: Mei, Yu, et al.
Publicado: (2017)

Correction: New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction
por: Zhao, Xiangyu, et al.
Publicado: (2022)

Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway
por: Xu, Tao, et al.
Publicado: (2019)

Osteoglycin as a Potential Biomarker of Mild Kidney Function Impairment in Type 2 Diabetes Patients
por: González-Salvatierra, Sheila, et al.
Publicado: (2021)

Cardiac ECM: Its Epigenetic Regulation and Role in Heart Development and Repair
por: Song, Rui, et al.
Publicado: (2020)

The Proteolysis of ECM in Intervertebral Disc Degeneration
por: Liang, Huaizhen, et al.
Publicado: (2022)

Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
por: Hu, Xiang, et al.
Publicado: (2018)

ECM signals ECM degradation
por: Powell, Kendall
Publicado: (2006)

Brusatol Inhibits Proliferation and Invasion of Glioblastoma by Down-Regulating the Expression of ECM1
por: Dai, Zhang’an, et al.
Publicado: (2021)

Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer
por: Stewart, Delisha A, et al.
Publicado: (2004)

The Effects of Acute High‐Intensity Interval Exercise and Hyperinsulinemic‐Euglycemic Clamp on Osteoglycin Levels in Young and Middle‐Aged Men
por: Bauer, Carlie, et al.
Publicado: (2022)

The ECM: To Scaffold, or Not to Scaffold, That Is the Question
por: Valdoz, Jonard Corpuz, et al.
Publicado: (2021)

Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells
por: Wang, Jiapeng, et al.
Publicado: (2021)

Proregenerative Properties of ECM Molecules
por: Plantman, Stefan
Publicado: (2013)

Deciphering the Relevance of Bone ECM Signaling
por: Alcorta-Sevillano, Natividad, et al.
Publicado: (2020)

The ECM-Cell Interaction of Cartilage Extracellular Matrix on Chondrocytes
por: Gao, Yue, et al.
Publicado: (2014)

Lysyl oxidase family members in urological tumorigenesis and fibrosis
por: Li, Tao, et al.
Publicado: (2018)

Dynamic photoelectrical regulation of ECM protein and cellular behaviors
por: Wang, Xiaozhao, et al.
Publicado: (2022)

Mimicking the physical cues of the ECM in angiogenic biomaterials
por: Crosby, Cody O, et al.
Publicado: (2019)

Self-Assembled Peptide Nanostructures for ECM Biomimicry
por: Marin, Davide, et al.
Publicado: (2022)

Obesity-Associated ECM Remodeling in Cancer Progression
por: Li, Junyan, et al.
Publicado: (2022)

Framing Heartaches: The Cardiac ECM and the Effects of Age
por: Ringström, Nathalie, et al.
Publicado: (2023)

Interview with the ECM Award winner 2022 and introducing the new ECM members
por: Son, Kiho, et al.
Publicado: (2023)

Exploring the cardiac ECM during fibrosis: A new era with next-gen proteomics
por: Sarohi, Vivek, et al.
Publicado: (2022)

ECM communicates with MMP
por: LeBrasseur, Nicole
Publicado: (2002)

ECM determines fate
por: Leslie, Mitch
Publicado: (2006)

Beyond the Matrix: The Many Non-ECM Ligands for Integrins
por: LaFoya, Bryce, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1c34uaejo8g9rubpdm094g5ceg